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Summary We have carried out a series of experiments to compare the response to radiation and drugs of
cells disaggregated from solid tumours as assayed by clonogenic survival and by an isotope incorporation
method. This latter assay consisted of measuring the 24h uptake of tritium labelled thymidine into cells plated
in liquid medium upon a layer of semi-solid agar. The isotope was administered 4 days after plating. For cells
from the RIF- 1 mouse tumour, good agreement was seen between response to radiation, adriamycin,
vincristine and CCNU as measured by the two assays. The two curves for radiation response, for example,
showed similar shoulders and subsequent exponential regions. For cells from xenografts of the NCI-H69
human small cell lung cancer line, the response to radiation was dose-related for both assays, but the curve
for clonogenic assay was about twice as steep as that for isotope uptake. For a range of five cytotoxic drugs,
good agrement was seen between the two assays over the first 1N decades of response but with a tendency for
the isotope uptake curve to plateau with further increasing drug dose.
It appears that, at least for these two well-defined experimental tumour systems, the isotope uptake assay
can provide a rapid quantitative assessment of cellular drug and radiation sensitivity comparable to that
provided by clonogenic assay but in a much shorter period of time.
Predictive sensitivity testing of cells from individual
patients' tumours has received much recent
attention. Much of the impetus has been provided
by the development of in vitro clonogenic assays for
cells taken directly from tumours (Hamburger &
Salmon, 1977; Courtenay & Mills, 1978). Although
these clonogenic assays have become widely used,
and it has been claimed that they can correctly
predict clinical response to cytotoxic drugs (Salmon
et al., 1978; von Hoff et al., 1981), a number of
severe problems remain. Among these are the
absolute requirement for a single cell suspension of
good viability, the very low plating efficiencies of
most tumour specimens (<0.1 %), the subjective
nature of colony assessment, and the length of time
needed to obtain a result (2-4 weeks). Various
alternatives to clonogenic assays have been
suggested, such as dye exclusion and isotope uptake
assays (Dendy et al., 1976; Durkin et al., 1979;
Volm et al., 1979; Morgan et al., 1983; Weisenthal
et al., 1983; Wilson et al., 1984). Whereas some
isotope assays examine very "short term" effects of
drug upon specific biochemical processes (Volm et
al., 1979; Sanfilippo et al., 1981). others are
dependent upon the establishment and proliferation
of cells in culture following removal from the
tumour (Dendy et al., 1976; Roper & Drewinko,
1976; Morgan et al., 1983; Wilson et al., 1984), in a
way which in many respects relates more closely to
a clonogenic assay but performed at a much earlier
stage of growth. A major problem with such assays
has been the potential contribution to proliferation
(and hence isotope uptake) of stromal cells present
in the tumour and able to proliferate for some time
on plastic or glass surfaces. In an attempt to
overcome this problem, Friedman & Glaubiger
(1982) have described a "liquid top" culture system
in which the tumour cells are plated in liquid
medium into dishes previously base-coated with a
solid layer of agar. The anchorage-dependent
stromal cells are unable to proliferate whereas the
anchorage-independent tumour cells aggregate and
proliferate. Using this system, Friedman &
Glaubiger (1982) showed that, for a variety of
human tumour samples, good agreement was seen
for predictions of drug sensitivity or resistance
between the isotope uptake assay and the human
tumour stem cell assay of Hamburger & Salmon
(1977).
In order to obtain more precise quantitative data
regarding the relationship between this [3H]TdR
uptake assay and clonogenic assay, we have carried
out experiments to obtain radiation and drug dose-
response curves for cells taken from an established
mouse tumour (RIF-1) and xenografts of the
human small cell lung cancer line NCI-H69. For
both tumour types, responses have been measured
using both assay systems and the results compared.
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Materials and methods
Tumours
The RIF-1 mouse sarcoma grows both as a solid
tumour in the C3H mouse and as a monolayer in
culture (Twentyman et al., 1980). Tumours were
initiated by the inoculation of 2 x 105 cells from
culture into the gastrocnemius muscle of the hind
leg and reached a volume of 500mm3 at 11-12 days
after injection. The host cell component of RIF-I
tumours has been measured at around 50% (Dr
D.W. Siemann, personal communication). The
human small cell lung cancer line NCI-H69 (kindly
supplied by Dr Desmond Carney) was maintained
in culture by weekly passage and xenografts were
initiated by the inoculation of 2-5 x 106 cells either
from culture or from a disaggregated xenograft
tumour into the gastrocnemius muscle of MFI
nude mice. Tumours reached a volume of
500mm3 at 2-4 weeks after injection. Histo-
logical examination of tumour sections showed
tightly packed round cells with little cytoplasm
and relatively little stroma.
For each response experiment, a pair of similar
tumours was excised under sterile conditions and
finely minced with scissors. The fragments were
then agitated for 1 h in culture medium containing
1 mgml- I of neutral protease (Sigma Type IX)
(Twentyman & Yuhas, 1980). At the end of this
time, the material was filtered through cotton
gauze, and centrifuged at 200g for 5min. The pellet
was resuspended in medium and a haemocytometer
count performed on the resulting single cell
suspension. Appropriate dilutions were then
prepared for treatment with radiation or drugs.
Treatments
For radiation treatments, a cell suspension was
prepared in 6ml Hanks balanced salt solution at
107cellsml-1. The suspension was placed in a
25cm2 tissue culture flask on the surface of a
bucket of crushed ice. The flask was then exposed
to incremental doses of 250kV X-rays and, after
each increment, 0.5ml of the suspension was
removed, placed into a plastic tube, and stored on
crushed ice. At the end of the radiation treatment
cells from the various groups were assayed for
response as below.
For drug treatments, freshly prepared drugs in
volumes of 10-200Ml were added to plastic tubes
containing 106 cells in 5 ml of the appropriate
culture medium. The media used for RIF-1 and
NCI-H69 cells were Eagles MEM with 20% new
born calf serum and modified Hams F12 with 15%
foetal calf serum respectively (see below).
Adriamycin (Farmitalia Ltd.) was dissolved in
water, melphalan (Chester Beatty Research
Institute) was dissolved in acidified ethanol,
vincristine (Eli Lilly) was dissolved in water, CCNU
(U.S. National Cancer Institute) was dissolved in
absolute ethanol and nitrogen mustard (mustine
hydrochloride, Boots) was dissolved in water. The
tubes were then incubated for 1 h at 37°C with
intermittent agitation. At the end of this period, the
cells were rinsed twice by centrifugation (5min at
200g) and resuspension and finally resuspended in
medium. Appropriate dilutions were then prepared
for the response assays as below.
Clonogenic assays
Cells from RIF-1 tumours were assayed for
clonogenic survival as previously described
(Twentyman et al., 1980) but with some
modifications. Varying numbers of cells were plated
into 90mm plastic petri dishes (Sterlin Ltd.)
containing a total of 11 ml of Eagles MEM with
20% new born calf serum and supplemented with
penicillin and streptomycin. Dishes were incubated
at 370C for 13 days in an atmosphere of 8% CO2
and 92% air. At the end of this time, the dishes
were rinsed in saline and stained in a solution of
crystal violet in methanol. Colonies containing at
least 50 cells were counted under a binocular
dissecting microscope. The routine plating efficiency
of RIF-1 cells was in the range 12-27%.
The clonogenic assay used for NCI-H69 cells
from xenograft tumours in nude mice was
essentially that of Courtenay & Mills (1978) in
which low oxygen tension and the addition of rat
red cells were used to optimise clonogenicity.
The medium used in this assay was modified
Hams F12 supplemented with 15% foetal calf
serum and with penicillin and streptomycin (all
supplied by Gibco Biocult Ltd.) Red blood cells
from August rats were obtained by cardiac
puncture using preservative-free heparin, separated
by centrifugation, rinsed 3 times with phosphate-
buffered saline (PBS) and resuspended to the
original blood volume in medium. The red cell
suspension was then heated to 44°C for 1h and
stored at 4°C for up to one month. A 1/8 dilution
in medium was carried out immediately before use
of the red cells. A 6% solution of Agar Noble
(Difco) in water was prepared and sterilized by
boiling for 15min. This was then diluted 1/10 in
prewarmed medium (44°C) to give a final
concentration of 0.6% and the solution kept at
44°C until required. Suspensions of the test cells in
medium were prepared at 2.5 x the required final
concentration and kept at 37°C.
For cloning, 2.0ml of the cell suspension was
added to 0.5ml of red cell suspension followed by
2.5ml of 0.6% agar solution. Aliquots of 1ml of
this suspension were then placed into each of 3 or 4
sterile plastic tubes (Falcon Plastics, No. 2051).
These tubes were stood in crushed ice until the agarCOMPARISON OF RESPONSE ASSAYS 627
set. They were then each gassed for 6 seconds with
a mixture of 90% nitrogen, 5% oxygen and 5%
carbon dioxide and the top of each tube "snapped"
closed. The tubes were placed in racks in plastic
cake boxes which were then gassed with the same
mixture for 10min before being sealed and
incubated at 37°C. After 7 and 14 days of
incubation, 1 ml of medium was added to the agar
plug in each tube and the tubes and boxes regassed.
At the end of the 21-day incubation period, the
agar plug was tipped out from each tube into the
inverted lid of a 5cm plastic petri dish. The base of
the dish was then pushed down onto the plug so
that the agar spread in a thin layer. Colonies
containing more than 50 cells were counted under
an inverted microscope. The plating efficiency of
cells from NCI-H69 xenografts was usually between
30 and 60% but values as low as 18% and as high
as 92% have occurred in single experiments.
Isotpe uptake assay
The tritium-labelled thymidine ([3H]TdR) uptake
assay used was essentially that of Friedman &
Glaubiger (1982) but with different media.
Experiments were carried out using 24-well plates
(Falcon) each well being 16mm in diameter.
Bottom layers containing Difco Noble Agar at a
concentration of 0.5% were prepared by boiling a
solution of 5% agar in water for 10min and then
diluting 1/10 with medium and holding at 44°C.
Aliquots of 0.5ml were then pipetted into each well
and these were stored in the refrigerator in plastic
boxes gassed with 5% C02/95% air until required.
Eagles medium with 20% new born calf serum was
used in both the bottom (agar) layer and the top
(liquid) layer for experiments with RIF-1 cells. For
NCI-H69 cells, the bottom layer contained RPMI
1640 medium with 10% foetal calf serum while the
top layer contained modified Ham's F12 medium
with 15% foetal calf serum. RPMI 1640 is the
standard medium used in this laboratory for the
growth of continuous cell lines of human small cell
lung cancer. Liquid top layers consisted of 1 ml of
medium containing the appropriate number of
control or treated cells. Preliminary experiments
were carried out in which different numbers of
control cells were plated out so as to establish the
range of linearity of the system (see Results
section). In response experiments, 104 RIF-1 cells
were used and, for NCI-H69, assays were carried
out using both 5 x 104 and 104 cells. Wells with 1 ml
of liquid medium but no cells were also included as
controls.
Well plates containing RIF-I cells were then
placed in a humidified gassing incubator (8%CO2
92% Air) at 37°C; while those containing NCI-H69
cells were incubated at 37°C in plastic boxes gassed
with 5% 02, 5% CO2 and 90% nitrogen. After 4
days, 0.5-2 21Ci [3H]TdR (49Cimmol-1,
Amersham International) was added to each well in
20pl PBS. The well was then incubated for a
further 24h. At the end of that time, the liquid
medium containing the cells was removed from the
surface of each well with a Pasteur pipette and
transferred to a plastic centrifuge tube containing
5ml of PBS. The agar was then rinsed twice with
1 ml of PBS and the washes added to the tube. The
sample was centrifuged for 0min at 200g, the
supernatant decanted and the pellet resuspended in
3ml of 5% trichloroacetic acid (TCA) in order to
precipitate protein and nucleic acids. After standing
on ice for Omin the sample was recentrifuged for
0min at 500g. All subsequent centrifugations were
performed at 5OOg for 10min. The supernatant was
decanted and the pellet resuspended in 3ml of
TCA. After Omin on ice the sample was
recentrifuged, the supernatant decanted and the
pellet resuspended in 3ml of absolute methanol.
This suspension was recentrifuged, the supernatant
decanted and 0.5ml of hyamine hydroxide (methyl-
benzethonium hydroxide, 1 M in methanol, Sigma)
was added. The sample was heated in a water bath
at 60°C to dissolve the pellet and then transferred
using a Pasteur pipette to a 5ml plastic liquid
scintillation counting insert vial containing 4ml of
Aquasol-2 (New England Nuclear). The sample
tube was washed twice with about 0.5ml of
Aquasol-2 from the insert vial and these washes
returned to the vial. The insert vial was placed into
a glass counting vial and stored in the dark 24h
before counting on a Nuclear Chicago Isocap 300
liquid scintillation counter.
Results
Linearity
Figure 1 shows typical data demonstrating a linear
relationship between the number of cells plated and
the amount of [3H]TdR incorporated into TCA-
precipitable material. Linearity was seen with RIF-1
cells over the range of 103-105 cells and with NCI-
H69 over the range of 10 -5 x 104 cells. For
subsequent response experiments, we used 104 cells
for RIF-1 and both 5 x 104 and 104 cells for NCI-
H69.
RIF-] experiments
Data for radiation and cytotoxic drug response of
cells from RIF-1 mouse tumours are shown in
Figures 2 and 3 respectively. The radiation response
curves (Figure 2) for the two assays were essentially
identical, showing initial shoulders and subsequent
exponential falls, although at each dose the isotope
uptake point is above the corresponding survival628 P.R. TWENTYMAN et al.
Dose (,ug ml-)
1 2 3
0.1 0.2 0.3
10 20 30
4
0.4
40
5 ADM
0.5 VCR
50 CCNU
A
0
"-
* _ _ AVCR
oN o~~ # A z- 1.
0 \A ADM
A
0
CCNU 4 0
Figure 1 Relationship between [3H]TdR uptake and
number of cells plated per well in the 1 ml liquid top
layer: (0) RIF-1 cells ([3H]TdR =2.0p Ci/well) (A)
NCI-H69 cells ([3H]TdR=0.5pCi/well).
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Figure 2 Change in cell surviving fraction (0) or in
[3H]TdR uptake as fraction of control (0) of RIF-1
cells treated with different doses of X-rays. The line is
fitted by eye to the surviving fraction data only.
Figure 3 Change in cell surviving fraction (closed
symbols) or in [3H]TdR uptake as fraction of control
(open symbols) of RIF-1 cells treated for 1 h with
different doses of cytotoxic drugs. CCNU (0, 0);
adriamycin (A, A); vincristine (-, C]). The lines are
fitted by eye to the surviving fraction data only.
12
point. The line fitted by eye to the surviving
fraction data has a slope (Do) of 1.76Gy and an
extrapolation number (n) of 4. For the cytotoxic
drugs (Figure 3), there was essentially no response
to vincristine (VCR) at any one of the doses used
for either assay. There was little or no effect of
adriamycin (ADM) at the three lowest doses but a
considerable response for both assays at Spgml-'.
A progressive response with increasing dose of
CCNU was seen in both assays. The excellent
agreement between the two assay systems seen in
these preliminary experiments provided impetus to
investigate the human lung cancer xenograft
response.
NCI-H69 xenograft experiments
The response of cells from NCI-H69 xenografts to
radiation and cytotoxic drugs in the two assay
systems are shown in Figure 4 (a-c). The results
shown are for 5 x 104 cells per well. The results for
104 cells per well were essentially identical. The
experiments for radiation, ADM and melphalan
(MEL) were carried out twice and gave closely
similar results to those shown. The radiation
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Figure 4 Change in cell surviving fraction (closed symbols) or in [3H]TdR uptake as fraction of control
(open symbols) of NCI-H69 cells treated with different doses ofX-rays (4a) or cytotoxic drugs (4b and 4c). In
4b, adriamycin (@, 0); melphalan (A, A). In 4c, vincristine (-, 0); nitrogen mustard (A, A); CCNU (U,
EI). The lines are fitted by eye to the surviving fraction data only.
response curves are somewhat different for the two
assay systems (Figure 4a). For the clonogenic
assaythereis asmallinitial shoulderwith asubsequent
exponential fall characterised by a Do of -0.72 Gy.
The repeat experiment yielded a curve with an
almost identical slope but without an initial
shoulder. For the isotope uptake assay the response
curve has little, if any, shoulder and is less steep. A
line fitted by eye to the points in the region
between 1 Gy and 6Gy has a slope corresponding
to a Do of 1.50Gy. The slope of the response curve
decreases at higher radiation doses at a level of
isotope uptake of -1% of control. The results for
ADM and MEL (Figure 4b) show excellent
agreement between the two assays for the first 12
decades of response but with a tendency for the
isotope uptake response to plateau at around 2
decades and therefore no longer be dose-related.
This same tendency was also seen for nitrogen
mustard (HN2) and CCNU (Figure 4c). The
responses to vincristine (VCR) (Figure 4c) were in
particularly good agreement over the two decades
of response measured.
The data from Figure 4 together with those from
repeat experiments (not shown) have been
combined in Figure 5 to demonstrate the
relationship between the surviving fraction and the
[3H]TdR uptake for all agents studied. The points
for radiation response are fitted by a curve which
indicates a rather greater response in terms of cell
survival than in terms of isotope uptake at all dose
levels. The curve fitted to all the drug data is
initially more shallow than the radiation curve,
indicating a somewhat greater effect on isotope
uptake, but becoming very steep at higher drug
doses when isotope uptake tends to plateau at
around 2 decades of response. We have not shown
a plot similar to Figure 5 for the RIF-1 data
because of the very close correspondence of the 2
assays for both radiation and drugs in this tumour.
Under these circumstances a plot similar to Figure
5 would show all points lying on or close to the
line of equivalence (i.e. slope= 1.0).
Discussion
There are remarkably few papers in the literature
where the results of clonogenic and non-clonogenic
assays have been directly compared in well-
characterised experimental systems. In general,
isotope uptake assays can be divided into "short
term assays" which measure the effect of cytotoxic
drugs on specific biochemical processes (e.g. DNA
or protein synthesis) within a very few hours of
removal from the tumour (Volm et al., 1979;
Sanfilippo et al., 1981) and those assays which
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Figure 5 Relationship between cell surviving fraction
and [3H]TdR uptake as fraction of control of NCI-
H69 cells treated with various cytotoxic agents.
Symbols are defined in the key. The solid line is fitted
by eye to the radiation response data and the broken
line to the data for a range of cytotoxic drugs.
depend upon the rate of proliferation of cells
established in culture some days after removal and
treatment. In this discussion, we will only consider
the latter type of assay as it is clearly more akin to
a clonogenic assay but performed at a much earlier
stage of growth. A study by Roper & Drewinko
(1976) examined the effect of cytotoxic drugs on the
clonogenicity and the [3H]TdR incorporation of
cells from a mouse lymphoma cell line. They
carried out the isotope uptake measurements at
various intervals from 1-5 days. Their conclusion
was that isotope uptake values were not clearly
dose-dependent at any given time-interval and did
not correlate with colony formation. More recently
Rupniak et al. (1983) compared cell survival in a
clonogenic assay and [3H]TdR labelling index
changes after drug treatment of a murine cell line.
Their 24h isotope labelling periods were either 24-
48h or 48-72h after plating. For the four drugs
examined, the labelling index was generally reduced
in circumstances where the clonogenic fraction was
reduced although it was not possible to define a
quantitative relationship between the two assays.
Two recent studies have made a less direct
comparison of drug sensitivity in cells both treated
and assayed under different conditions. Morgan et
al. (1983) compared the sensitivity of short-term
cultures of human gliomas to various drugs by
determining the drug doses necessary to depress
either clonogenicity or monolayer [3H] leucine
incorporation by 50 or 90%. A high degree of
correlation between the 2 methods was seen when
comparing ID50 values but not when comparing
ID90 values. In a comparison of a clonogenic assay
and a monolayer isotope uptake assay, Wilson et
al. (1984) showed for 2 cell lines that although the
assays did not produce identical dose-response data
they each showed a dose-dependent response. For
each assay it was possible, on the basis of
retrospective clinical response data, to choose a cut-
off point for response which made the assay valid
for further predictive testing.
In the original report by Friedman & Glaubiger
(1982) which first described the "liquid top" assay
which we have used, they compared isotope uptake
results with clonogenic assay for 61 drug tests on
human cell lines and clinical tumour samples. They
state that drug resistance/sensitivity determinations
(defined by arbitrary but consistent criteria) agreed
in 54 of 61 determinations, and furthermore that in
22 experiments in which drug sensitivity curves (2
or 3 dose levels) were compared 21 were "similar"
in both assay systems. Very recently Friedman et al.
(1983) have used their system to obtain dose-effect
curves for the radiation response of a Chinese
hamster ovary cell line and found the results to be
closely similar to those obtained with clonogenic
assay. Furthermore dose-effect relationships were
obtained for the radiation response of 3 primary
human tumour biopsy specimens and these showed
a conventional exponential fall. These data together
with those which we report in this paper appear to
indicate that, for l}-2 decades of response, the
[3H]TdR "liquid top" assay produces better
agreement with clonogenic assay (for the same
treated population of tumour cells) than has been
previously reported. Although agreement over 3 or
more decades of response would be preferable, it
must be remembered that most currently used
clonogenic assays for predictive testing rely upon a
reduction of colonies to only 50% or 30% of the
initial value in order to predict sensitivity (Salmon
et al., 1978; Von Hoff et al., 1981). The extremely
low plating efficiency of most human tumour
biopsy specimens means that study over more than
1 decade of response is generally impractical. There
are clearly differences between the assays in that,
for instance, the radiation and drug data in Figure
5 are fitted by somewhat different lines. It is
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certainly not, of course, to be expected that any
two response assays will provide identical dose-
effect curves over a wide range of responses and
agents. Whereas the clonogenic assay will measure
only the long-term survival of cells in a "yes or no"
manner, the isotope uptake assay will additionally
reflect the various lengths of division delay induced
by different agents and also any changes in the
subsequent proliferation rate of surviving cells. If,
for instance, the mean colony size is reduced by a
given treatment, this factor will not be accounted
for in a clonogenic assay but would be expected to
produce a reduced isotope uptake. To what extent
the various aspects of "response" are involved in
determining the relatively short term clinical
responses used to validate predictive testing remains
a matter of speculation. Even in well-established
experimental animal tumours the relationship
between tumour growth delay and clonogenic cell
survival is complicated by a very wide range of
factors (Twentyman, 1980). What is required in
assessing the comparative validity of two response
assays is that each assay be able to provide a
quantitative dose-effect relationship over a similar
range of doses. We believe that the [3H]TdR "liquid
top" assay fulfils this requirement when compared
with clonogenic cell survival.
Our further studies are aimed at optimising the
media, and growth conditions for a variety of
primary human types and also determining the
contribution of non-tumour cells present in clinical
specimens to isotope uptake under the conditions of
the assay. Should the initial promise of the method
stand up to further investigation, the "liquid top"
assay, producing results within 6 days, should
prove a useful tool in the determination of human
tumour sensitivity characteristics.
We thank Dr Paul Workman for providing the
xenografted tumours used in this study, and Professor
N.M. Bleehen for his continuing interest and discussion of
this work.
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